Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Edoxaban Tosylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,911Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3DAIICHI SANKYO INC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    DAIICHI SANKYO INC

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EDOXABAN TOSYLATE

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    M-14
    2026-10-18
    206316
    1
    blank

    01

    DAIICHI SANKYO INC

    EDOXABAN TOSYLATE

    arrow
    2024 ACI Convention
    Not Confirmed

    DAIICHI SANKYO INC

    Japan
    arrow
    2024 ACI Convention
    Not Confirmed

    EDOXABAN TOSYLATE

    Exclusivity Code : M-14

    Exclusivity Expiration Date : 2026-10-18

    Application Number : 206316

    Product Number : 1

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    DAIICHI SANKYO INC

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EDOXABAN TOSYLATE

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    M-14
    2026-10-18
    206316
    3
    blank

    02

    DAIICHI SANKYO INC

    EDOXABAN TOSYLATE

    arrow
    2024 ACI Convention
    Not Confirmed

    DAIICHI SANKYO INC

    Japan
    arrow
    2024 ACI Convention
    Not Confirmed

    EDOXABAN TOSYLATE

    Exclusivity Code : M-14

    Exclusivity Expiration Date : 2026-10-18

    Application Number : 206316

    Product Number : 3

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    DAIICHI SANKYO INC

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EDOXABAN TOSYLATE

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    M-14
    2026-10-18
    206316
    2
    blank

    03

    DAIICHI SANKYO INC

    EDOXABAN TOSYLATE

    arrow
    2024 ACI Convention
    Not Confirmed

    DAIICHI SANKYO INC

    Japan
    arrow
    2024 ACI Convention
    Not Confirmed

    EDOXABAN TOSYLATE

    Exclusivity Code : M-14

    Exclusivity Expiration Date : 2026-10-18

    Application Number : 206316

    Product Number : 2

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF